Unique ID issued by UMIN | UMIN000000957 |
---|---|
Receipt number | R000001150 |
Scientific Title | Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery |
Date of disclosure of the study information | 2007/12/27 |
Last modified on | 2010/01/14 10:35:31 |
Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
JL-Knight Study
(Japan Landiolol-Kicking off the novel investigation for gold standard heart study)
Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
JL-Knight Study
(Japan Landiolol-Kicking off the novel investigation for gold standard heart study)
Japan |
tachyarrhythmia
Cardiology | Anesthesiology | Cardiovascular surgery |
Intensive care medicine |
Others
NO
The efficacy of beta-blocker,Landiolol hydrochloride versus calcium channel blocker,Diltiazem hydrochloride are compared in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery.
Safety,Efficacy
Confirmatory
Pragmatic
Phase IV
Atrial fibrillation / atrial flutter (heart rate control, converting rate to normal sinus rhythm, palindromia rate)
Ischemic changes
Changes of blood pressure
Manifestation rate of bradycardia,atrioventricular block and cardiovascular events
Length of ICU and hospitalization
Cost of medical care after cardiovascular surgery
Mortality rate in nosocomial
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
Numbered container method
2
Treatment
Medicine |
Intravenous beta-blocker, Landiolol hydrochloride for up to 24 hrs
Intravenous calcium channel blocker, Diltiazem hydrochloride for up to 24 hrs
20 | years-old | <= |
85 | years-old | > |
Male and Female
Patients after cardiovascular surgery
*postoperative atrial fibrillation / atrial flutter with a ventricular rate more than or equal to 110 b.p.m. for a duration more than or equal to 5 min within 7 days after surgery
(1) acute myocardial infarction within 3 days
(2) supraventricular arrhythmia
(3) sick sinus syndrome (containing patients with pacemaker)
(4) grave heart failure (preoperative NYHA Classification of the Stages of Heart Failure, more than or equal to third degree)
(5) atrioventricular block, more than or equal to second degree
(6) contraindication to beta-blockers or , calcium channel blockers
(7) electrolyte imbalance, WPW syndrome or hyperthyroidism
(8) blood pressure < 90/60 mmHg
(9) postoperative peroral use of beta-blockers or, calcium channel blockers
(10) use of operative and postoperative antiarrhythmic medications excluding Digitalis
400
1st name | |
Middle name | |
Last name | Atsuhiro Sakamoto |
Nippon Medical School
Department of Anesthesiology
1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan
03-5814-6243
1st name | |
Middle name | |
Last name | Chol Kim |
Nippon Medical School
Department of Anesthesiolgy
1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan
03-5814-6243
kim-nms@umin.net
JL-Knight Study Group
none
Self funding
NO
2007 | Year | 12 | Month | 27 | Day |
Unpublished
Completed
2007 | Year | 12 | Month | 01 | Day |
2008 | Year | 01 | Month | 01 | Day |
2009 | Year | 12 | Month | 01 | Day |
2010 | Year | 01 | Month | 01 | Day |
2010 | Year | 02 | Month | 01 | Day |
2010 | Year | 03 | Month | 01 | Day |
2007 | Year | 12 | Month | 26 | Day |
2010 | Year | 01 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001150